Suppression of oxidative phosphorylation confers resistance against bevacizumab in experimental glioma

Jule A. Eriksson, Christina Wanka, Michael C. Burger, Hans Urban, Ines Hartel, Janusz von Renesse, Patrick N. Harter, Michel Mittelbronn, Joachim P. Steinbach*, Johannes Rieger

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

9 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Suppression of oxidative phosphorylation confers resistance against bevacizumab in experimental glioma'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science